行业研究公司研究宏观策略财报招股书会议纪要 seedance2.0 低空经济 DeepSeek AIGC 大模型

第23版，《世界卫生组织卫生紧急情况方案流行病学公报》，世界卫生组织东南亚区域办事处，2025年11月19日。报告期：2025年10月3日至11月16日

2025-11-19 世界卫生组织车伟光

关键事件与更新

世界卫生组织东南亚区域免疫技术顾问组第十六次会议：于2025年9月16日至18日在印度新德里以混合形式举行。会议重点加速区域免疫接种工作，回顾了2022-2026年区域免疫接种战略（RVIP）的进展，并讨论了零剂量儿童、区域内部差异和监测空白等挑战。会议还启动了关于2026年后RVIP的专家咨询，并强调了区域合作机制的重要性。
免疫接种领域的变化：会议讨论了资源限制、捐赠者优先事项转变和弹性卫生系统需求对免疫接种环境的影响，展示了SEAR-ITAG在维持免疫接种成就、推进公平性策略和促进合作方面的持续承诺。

流感

东南亚区域情况：截至2025年11月18日，区域每周流感检测阳性率为10%，共检测3267个样本，其中339例（10%）为流感阳性。马绍尔群岛（27%）、斯里兰卡（39%）和泰国（34%）的阳性率最高。
病毒亚型和谱系：在2025年第44-45周，东南亚区域以A(H3)亚型为主，其中马绍尔群岛（83%）、不丹（76%）、泰国（75%）和斯里兰卡（68%）的A(H3)阳性率最高。

新型冠状病毒（COVID-19）

东南亚区域情况：截至2025年11月9日，基于整合的流感-新冠病毒哨点监测系统数据，总结了孟加拉国、不丹、印度、马尔代夫、尼泊尔、斯里兰卡、泰国和东帝汶八个国家的每周趋势。

豆疹（Mpox）

东南亚区域情况：截至2025年11月16日，印度报告了2例新增豆疹病例。自2022年7月14日以来，区域共报告1145例实验室确诊病例，其中14例死亡。区域报告了20例MPVX Ib谱系病例，其中10例来自印度，10例来自泰国。

登革热

孟加拉国：2025年第46周报告了6454例新增登革热病例，较前一周下降6%；报告了23例死亡，较前一周下降23.3%。
印度：2025年10月报告了22659例登革热病例，较9月增加21%。截至2025年10月31日，全年累计报告91015例，较2024年同期减少。
马尔代夫：2025年9月报告了254例登革热病例，较8月下降2.3%。
尼泊尔：2025年10月报告了1644例登革热病例，较9月增加7.7%。
斯里兰卡：2025年第45周报告了777例新增登革热病例，较前一周增加7.2%。
泰国：2025年9月报告了4012例登革热病例，较8月下降53%；报告了1例死亡，较8月下降83%。

Thisepidemiological bulletin aims to providethe situation of key infectiousdiseases intheWHOSouth-East AsiaRegionto inform risk assessmentsand responses. The bulletin usesinformation from publicly availablesources and Key events and updates......................................................................................................................2New publication: Sixteenth Meeting of the WHO South-East Asia Regional Immunization Technical AdvisoryGroup.......................................................................................................................................................................2Influenza............................................................................................................................................3Situation in the WHO South-East Asia Region..........................................................................................................3COVID-19............................................................................................................................................5Situation in the WHO South-East Asia Region..........................................................................................................5Mpox.................................................................................................................................................7Situation in the WHO South-East Asia Region..........................................................................................................7Dengue...............................................................................................................................................9Bangladesh...............................................................................................................................................................9India........................................................................................................................................................................10Maldives..................................................................................................................................................................12Nepal.......................................................................................................................................................................12Sri Lanka..................................................................................................................................................................13Thailand..................................................................................................................................................................14 Key eventsand updates New publication: Sixteenth Meeting of the WHO South-East Asia Regional Immunization The WHO South-East Asia Regional Immunization Technical Advisory Group(SEAR-ITAG)serves as the regional forum for providing independent,evidence-based recommendations on immunization policies and strategieswithin the Region. Established by the WHO Regional Director for South-EastAsia, SEAR-ITAG plays a central role in shaping the regional immunization SEAR-ITAG is composed of experts from diverse fields including programmemanagement,communicable disease control,virology,epidemiology,immunization, and behavioural sciences. The group convenes annually, andasneeded,to review progress,identify emerging challenges,andrecommend strategic actions aimed at strengthening immunization systems The sixteenth meeting of SEAR-ITAG was conducted in a hybrid format in NewDelhi, India, from 16 to 18 September2025. This meeting marked a critical milestone in the Region’s immunization efforts, focusing on accelerating This year’s meeting built upon the outcomes ofseveral key regional forums,including the Regional CertificationCommission for Polio Eradication (SEA-RCCPE), the Regional Verification Commission for Measles and RubellaElimination (SEA-RVC), the Annual Regional Working Group (RWG) meeting, and a special session of SEAR-ITAG held Taking place as the Region nears completion of the RVIP 2022–2026, the meetingaimed to:review national and regional progress towards RVIP goals; ••address ongoing challenges such as zero-dose children, subnational disparities,•and surveillance gaps;•initiate expert consultations regarding the next RVIP beyond 2026; and•reinforce mechanisms for regional collaboration and accountability. The meeting further addressed the evolving immunizationlandscape, shaped byresource constraints, shiftingdonor priorities, and the need for resilient health systems. Discussions demonstrated SEAR-ITAG’s continuedcommitmentto sustaining immunization achievements,advancing equity-driven strategies,and fostering As a trusted advisory entity, SEAR-ITAG continues to guide WHO and its MemberStates in addressing compleximmunization challenges—ensuring that no one is left behind in the pursuit of universal vaccine access and disease I

点击免费查看完整报告